Tech Company Financing Transactions
Upfront Diagnostics Funding Round
Upfront Diagnostics, based in Cambridge, secured $2 million from APEX Ventures, SBRI Healthcare and Stroke Association.
Transaction Overview
Company Name
Announced On
6/27/2023
Transaction Type
Venture Equity
Amount
$2,025,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to scale its technology and its accuracy for identifying a large artery stroke, expand its team and prepare for clinical approval.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
University of Cambridge Li Ka Shing Centre Robinson Way
Cambridge, CB2 0RE
UK
Cambridge, CB2 0RE
UK
Phone
Website
Email Address
Overview
Upfront diagnostics was founded in November 2017 in Cambridge, United Kingdom. We are a group of Cambridge students and young entrepreneurs focused on discovering biomarkers that can be applied to improve medical diagnosis. We have built the first blood test for large vessel occlusion stroke diagnosis called "LVOne", enabling a faster and more accurate stroke diagnosis that improves treatment and can help clinicians saving lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gonzalo Ladreda
Chief Medical Officer
Joshua Bernstock
Chief Scientific Officer
Edoardo Gaude
Browse more venture capital transactions:
Prev: 6/27/2023: Nuvocargo venture capital transaction
Next: 6/27/2023: Carthera venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs